Your session is about to expire
← Back to Search
Tasimelteon Oral Capsule, Tasimelteon Liquid Suspension for Autism Spectrum Disorder
Study Summary
This trial will test if tasimelteon can help with sleep problems in people with ASD.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are we currently looking for more participants for this experiment?
"This is an active clinical trial that was first posted on 7/28/2021, as indicated by the website clinicaltrials.gov. The most recent update to the study was on 4/29/2022."
Does this trial have an upper age limit for participants?
"This trial is open to patients aged 2 to 65. In total, there are 481 clinical trials for children and 844 for adults over the age of 65."
How many volunteers are helping with this research?
"That is correct, the clinicaltrials.gov website does show that this study is actively recruiting participants. The trial was originally posted on July 28th, 2021 and was edited most recently on April 29th, 2022. The research team hopes to enroll 100 patients from 5 different medical sites."
Are there specific inclusion criteria for subjects of this research?
"Eligible participants for this clinical trial should have a diagnosis of autism spectrum disorder and be aged 2 to 65. The researchers are looking to enroll 100 patients in total."
In how many different geographical areas is this trial being conducted?
"At the moment, there are 5 sites conducting this clinical trial. They are situated in San Jose, Boulder and Staten Island as well as 2 other locations. If you wish to enroll in the study, try and choose a site close to your residence to reduce travel time commitments."
What are the potential side effects of Tasimelteon Oral Capsule and Tasimelteon Liquid Suspension?
"Tasimelteon Oral Capsule, Tasimelteon Liquid Suspension is classified as a Phase 3 trial medication. This means that there is some data supporting efficacy and multiple rounds of data supporting safety. Consequently, our team at Power rates the safety of this drug as a 3 on a scale from 1 to 3."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger